SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-004738
Filing Date
2021-11-18
Accepted
2021-11-17 17:31:36
Documents
12
Period of Report
2021-11-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srne-20211115.htm   iXBRL 8-K 93656
  Complete submission text file 0000950170-21-004738.txt   209230

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20211115.xsd EX-101.SCH 2434
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20211115_pre.xml EX-101.PRE 10441
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20211115_lab.xml EX-101.LAB 12798
5 EXTRACTED XBRL INSTANCE DOCUMENT srne-20211115_htm.xml XML 4520
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 211421665
SIC: 2836 Biological Products, (No Diagnostic Substances)